施他宁在急性坏死性胰腺炎治疗中的应用  

Somatostatin in the Therapy of Acute Necrotizing Pancreatitis

作　　者：周惠清[1] 姜靖寰[1] 王如涛[1] 陈梅梅[1] 章莉[1] 

机构地区：[1]上海第二医科大学附属新华医院,200092

出　　处：《胃肠病学》1998年第1期18-19,共2页Chinese Journal of Gastroenterology

摘　　要：目的:探讨施他宁在急性坏死性胰腺炎治疗中的作用。方法:1995年8月至1996年9月本院消化科共收治急性坏死性胰腺炎27例,其中24例用施他宁治疗,3例转外科手术治疗。结果:用施他宁保守治疗的24例患者中除2例死亡外均存活,存活率92％,转外科手术3例中2例死亡。结论:施他宁不失为一个治疗急性坏死性胰腺炎的良药,能大大地提高患者的存活率。Background/Aims: To study the effection of somatostatin in treating acute necrotizing pancreatitis. Methods: 27 patients with acute necrotizing pancreatitis were observed from August 1995 to September 1996. 24 of them were treaded by somatostatin, 3 of them underwent operation. Results: The surviving rate of treatment by somatostatin in acute necrotizing pancreatitis is 92% except 2 patients dead. Two of the three operative patients were dead. Conclusion: Somatostatin is a useful and effective drug for acute necrotizing pancreatitis and greatly enhancing the surviving rate.

关 键 词：施他宁 急性坏死性胰腺炎 治疗 

分 类 号：R576[医药卫生—消化系统]